Smith & Nephew Seeks To Buy India's Adler Mediequip For $300 Million
This article was originally published in PharmAsia News
India's Adler Mediequip Private, maker of medical devices for use in treating traumas, is the target of a $300 million buyout effort by the U.K.'s Smith & Nephew, which said it intends to acquire the company and its brands.
You may also be interested in...
Chief medical officer Samit Hirawat outlines R&D successes – though there have been some setbacks since it bought Celgene for $74bn last year – and the company’s commitment to clinical trial diversity.
Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.